Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET
Company Participants
Susan Morrison - Executive VP & Chief Administrative Officer
John Sheridan - President, CEO & Director
Leigh Vosseller - EVP, CFO & Treasurer
Conference Call Participants
Matt Miksic - Barclays
Brooks O'Neil - Lake Street Capital Partners
Chris Pasquale - Nephron Research
Matthew O'Brien - Piper Sandler
Steve Litchman - Oppenheimer
Matt Taylor - Jefferies
Alex Nowak - Craig-Hallum
Jayson Bedford - Raymond James
Jeff Johnson - Baird
Travis Steed - Bank of America
Josh Jennings - Cowen
Matthew Blackman - Stifel
Operator
Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Susan Morrison, EVP and Chief Administrator Officer. Please go ahead
Susan Morrison
Hello, everyone, and thank you for joining Tandem's third quarter earnings call. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.
A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or other factors.
In addition, today's discussion will include references to a number of GAAP and non-GAAP financial measures. Non-GAAP financial measures are provided to give our investors information that we believe is indicative of our core operating performance and reflects our ongoing business operations. We believe these non-GAAP financial measures facilitate better comparisons of operating results across reporting periods. For additional information about our use of non-GAAP financial measures, please refer to our press release issued earlier today.